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Abstract Chlorohydrins of stearoyl-oleoyl phosphatidylcholine
(SOPC), stearoyl-linoleoyl phosphatidylcholine, and stearoyl-
arachidonyl phosphatidylcholine were incubated with cultured
myeloid cells (HL60) for 24 h, and the cellular ATP level was
measured using a bioluminescent assay. The chlorohydrins
caused signi¢cant depletion of cellular ATP in the range 10^
100 WM. The ATP depletion by the phospholipid chlorohydrins
was slightly less than that of 4-hydroxy-2-nonenal, but greater
than that of hexanal, trans-2-nonenal, and autoxidised palmito-
yl-arachidonoyl phosphatidylcholine. SOPC chlorohydrin was
also found to cause loss of viability in U937 cells, and thus
phospholipid chlorohydrins could contribute to the formation
of a necrotic core in advanced atherosclerotic lesions.
0 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Atherosclerosis is now increasingly regarded as an in£am-
matory condition, in which immune cells play a signi¢cant
role [1]. It is also well established that the oxidation of low
density lipoprotein (LDL) is a key risk factor for atheroscle-
rosis [2], and that oxidised LDL (oxLDL) can contribute to
the disease pathology via several di¡erent mechanisms. There
is evidence that oxLDL has many biological e¡ects including
cytotoxicity, proliferation of smooth muscle cells and mono-
cytes, binding of monocytes to the endothelium, stimulation
of cytokine release and interference with endothelium-medi-
ated relaxation [3,4].
In view of the pro-in£ammatory and pro-atherogenic e¡ects
of oxLDL, it is important to de¢ne the precise components of
oxLDL which may be responsible for some or all of these
e¡ects. Peroxidation of polyunsaturated LDL lipids has long
been an area of interest, as it is well established that the
aldehyde breakdown products of lipid peroxides have a vari-
ety of deleterious e¡ects in biological systems. Malondialde-
hyde, a commonly measured marker of lipid peroxidation,
reacts readily with several protein sidechain groups, causing
loss of protein function [5]. Another lipid peroxidation prod-
uct, 4-hydroxynonenal (HNE), has been found to be cytotoxic
and bioactive through a wide variety of di¡erent mechanisms,
as reviewed recently by Poli and Schaur [6].
More recently, interest has developed in hypochlorous acid
(HOCl) as a potential oxidant of LDL in vivo. HOCl is pro-
duced by the enzyme myeloperoxidase [7], which is present in
monocytes and at high levels in neutrophils. There is mount-
ing evidence for the involvement of myeloperoxidase and
HOCl in atherosclerosis ; myeloperoxidase has been detected
in an active form in atherosclerotic lesions [8], and HOCl-
modi¢ed epitopes of LDL have been detected in lesions using
a speci¢c monoclonal antibody [9]. Chlorotyrosine derivatives
have been detected at all stages of lesion development and are
elevated in LDL from atherosclerotic intima [10]. Moreover, it
has been found that HOCl-modi¢ed LDL can induce inter-
leukin-8 expression and cause chemotactic migration of neu-
trophils [11]. HOCl can react with unsaturated fatty acids
to form chlorohydrins [12], and it has been reported that
chlorohydrins and bromohydrins of oleic acid are toxic to
endothelial cells, causing lysis and necrotic cell death [13].
Treatment of isolated human LDL with either HOCl or
myeloperoxidase, at concentrations similar to those thought
to occur in atherosclerotic lesions, results in generation of
phospholipid chlorohydrins [14], and therefore it is also im-
portant to determine the biological e¡ects of these com-
pounds, in order to understand their potential contribution
to atherosclerotic progression. In this study, we have prepared
speci¢c phosphatidylcholine chlorohydrins, and examined
their ability to deplete cellular ATP in cultured human mye-
loid cells, in comparison with the aldehydes hexanal, 2-trans-
nonenal and HNE, and autoxidised palmitoyl-arachidonoyl
phosphatidylcholine (PAPC). The toxicity of SOPC chlorohy-
drin was also compared with that of HNE. This is the ¢rst
report of the cellular e¡ects of chlorinated derivatives of phos-
pholipids.
2. Materials and methods
2.1. Preparation of chlorohydrins
All phospholipids were purchased from Sigma. Stearoyl-oleoyl
phosphatidylcholine (SOPC), stearoyl-linoleoyl phosphatidylcholine
(SLPC), stearoyl-arachidonoyl phosphatidylcholine (SAPC), and
PAPC were prepared individually in chloroform at a concentration
of 10 mg/ml. Aliquots of each lipid were dried under nitrogen and
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reconstituted by whirlimixing in an equal volume of Hanks-bu¡ered
saline solution (HBSS), followed by sonication at 35‡C for 15 min, to
form lipid vesicles. The vesicles were treated with a 10-fold molar
excess of sodium hypochlorite at pH 6.0 until approximately complete
conversion of the native phospholipid was achieved (between 15 and
50 min, depending on the lipid used). Excess hypochlorite was re-
moved by passing the incubation mixture through a Sep-pak cartridge
(Waters, UK) and eluting the phospholipid with 1:1 methanol:chloro-
form followed by 100% chloroform. The organic solvent was removed
under a stream of nitrogen and the phospholipid chlorohydrins were
reconstituted in HBSS and ¢ltered through a 0.2 micron gamma-steri-
lised ¢lter prior to addition to the cells.
2.2. Analysis of chlorohydrins and autoxidised PAPC
The conversion of native lipids to chlorohydrins was monitored
following the reaction period and after elution from the Sep-pak col-
umn by electrospray mass spectrometry (ESMS). One Wl aliquots were
removed and diluted 200-fold with 71:5:7 (v/v/v) methanol:hex-
ane:0.1 M ammonium acetate. ESMS was carried out on Platform
(VG) or LCQ-Duo (Finnigan) mass spectrometers in positive ion
mode by direct infusion. A spectrum in the range 400^1050 m/z was
obtained, and both loss of the native lipids and appearance of chlo-
rohydrins at multiples of +52/+54 m/z were monitored as described
previously [14].
A 50 Wl aliquot of PAPC (10 mg/ml in chloroform) was dried under
nitrogen and allowed to autoxidise in the dark at 40‡C for 100 h. The
lipid was reconstituted in 50 Wl of chloroform and diluted 200-fold in
ESMS running solvent. Spectra were collected on an LCQ-Duo be-
tween 400 and 1100 m/z to obtain a pro¢le of the autoxidation prod-
ucts.
2.3. Preparation of aldehydes
Hexanal and trans-2-nonenal were prepared in UHP water, and
HNE was prepared in ethanol, to give stock solutions of 100 mM
which were sterilised by ¢ltration at 0.2 micron. The quality of an
aqueous dilution of the HNE preparation was checked by UV absor-
bance for the occurrence of a single maximum at 223 nm, and the
concentration was con¢rmed using O=13 750 M31 cm31. Further di-
lutions to two times the ¢nal required concentrations of the aldehydes
were made in RPMI-1640 medium using sterile procedures.
2.4. Cell culture and treatment
HL60 and U937 cell lines (ECACC) were cultured at 37‡C in
RPMI-1640 medium containing 2 mM L-glutamine and 25 mM
HEPES, and supplemented with 10% foetal calf serum. Some experi-
ments were also carried out in medium containing low levels of foetal
calf serum (0.5%). Treatment with the test compounds was carried out
in 96-well luminescence plates (Greiner, UK), with 1U104 cells per
well (100 Wl volume). Aliquots (100 Wl) of the sterile chlorohydrin or
aldehyde preparations were added to wells, and the plate was incuba-
ted at 37‡C in a humidi¢ed atmosphere with 95% O2 and 5% CO2 for
24 h. The treatment concentrations used were 0, 10, 25, 50, 100, 150
and 200 WM for both phospholipid chlorohydrins and aldehydes. Ad-
ditionally for the phospholipids, a set of control incubations were
carried out with the native lipids at the same concentrations.
A 24 h timecourse was carried out with U937 cells incubated with
100 WM SOPC chlorohydrin. Samples from the 96-well culture plate
were removed and analysed at 0, 2, 4, 6, 8, 22 and 24 h.
2.5. Analysis of cellular ATP levels
Following incubation with the test compounds, the cellular ATP
concentration was determined by the CellTitre-GloTM Luminescence
assay (Promega, UK), which measures the intracellular ATP level
using the ATP-dependent luciferin^luciferase reaction. The assay
was performed according to the manufacturer’s instructions, before
recording the luminescence on a LUMIstar Galaxy Luminometer
(BMG Labtechnologies, Aylesbury, UK). The integration time per
well was 3 s and the gain was set at 100. The luminescence was
recorded as relative light units per second, and the results are ex-
pressed as a % of control ATP, to allow comparison between individ-
ual experiments.
2.6. Analysis of viability by the MTT assay
U937 cell treatments with SOPC chlorohydrin and HNE (concen-
trations indicated in Fig. 6) were carried out as described in Section
2.4 but using 1U105 cells per well. After 24 h incubation, 10 Wl of
sterile 10 mg/ml MTT solution (3-[4,5-dimethylthiazol-2-yl]-2,5-diphe-
nyltetrazolium bromide) dissolved in RPMI-1640 medium (without
phenol red) was added to the wells, and the plate was incubated for
90 min at 37‡C. The plate was centrifuged for 10 min at 600Ug, the
supernatant was removed and 200 Wl of 3:1 dimethylsulfoxide
(DMSO):isopropanol (v/v) was added to each well. The plate was
shaken for 15 min before reading the absorbance at 540 nm in a
Labsystems iEMS Reader.
3. Results
The e¡ect of three aldehydes, hexanal, trans-2-nonenal and
HNE, on the human myeloid cell line HL60 was tested to
provide a standard against which the phospholipid chlorohy-
drins could be compared, as aldehydes are already known to
have various biological e¡ects on many cells, including tox-
icity, and HNE in particular has been much studied [6]. Fig. 1
shows that hexanal had very little e¡ect on the cells, with the
only signi¢cant decrease in ATP concentration occurring with
the 200 WM treatment, where the [ATP] was found to be 90%
of the control (P6 0.01). The response of the cells to trans-2-
nonenal was similar, with a signi¢cant decrease in [ATP] also
Fig. 1. The e¡ect of aldehydes on cellular ATP in HL60 and U937
cells. Cells were incubated for 24 h in RPMI-1640 medium contain-
ing aldehydes at the concentrations indicated in the graphs. Follow-
ing treatment, the cellular ATP level of the cells was determined us-
ing luciferin^luciferase in a bioluminescent assay, and the % ATP
level of the cells was calculated by comparison with untreated cells.
The top graph shows the e¡ect of hexanal and trans-2-nonenal on
HL60 cells, and the bottom graph shows the e¡ect of HNE on
U937 and HL60 cells. The data are the average of three separate
experiments each carried out in triplicate, and the error bars corre-
spond to 1 S.D.
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only observed at 200 WM (P6 0.01), although the loss of ATP
that occurred was greater, as the cells contained approxi-
mately 60% compared to the control. In contrast, HNE was
found to have a much more severe e¡ect, with 10 WM already
causing a substantial reduction in ATP levels in HL60 cells to
40% of the control value, and concentrations of 25 WM and
higher resulting in almost complete loss of ATP. The response
of U937 cells to HNE almost exactly paralleled that of the
HL60 cells.
The e¡ect of native phospholipids and the phospholipid
chlorohydrins on HL60 cells was then investigated. The con-
version of the native phospholipids was monitored by ESMS
and representative spectra showing the composition of the
chlorohydrin preparations are shown in Fig. 2. Treatment of
SOPC and SLPC resulted in almost complete conversion to
the chlorohydrin forms, and for SLPC the bis-chlorohydrin
predominated. The conversion of SAPC to chlorohydrins was
less complete, with about 40^50% conversion typically
achieved, and mono-, bis-, and tris-chlorohydrins were all
observed. In initial experiments, the cells were assessed after
Fig. 2. Conversion of phospholipids to chlorohydrin products. The
formation of chlorohydrins was monitored using ESMS for each of
the phospholipids tested. Top spectrum: SOPC treatment with na-
tive lipid at 788 m/z (M-Hþ ion) and 810 m/z (M-Naþ ion), mono-
chlorohydrins at 840 m/z (M-Hþ ion) and 862 m/z (M-Naþ ion).
Middle spectrum: SLPC treatment with native lipid at 786 m/z (M-
Hþ ion) and 808 m/z (M-Naþ ion), bis-chlorohydrins at 890 m/z
(M-Hþ ion) and 912 m/z (M-Naþ ion). The signal at 872 m/z ap-
pears to be an in-source dehydration product of the chlorohydrin,
not a glycol, as it demonstrates a typical 37Cl-isotope pattern. Bot-
tom spectrum: SAPC treatment with native lipid at 810 m/z and
832 m/z, mono-chlorohydrin forms at 862 and 884 m/z, bis-chloro-
hydrin forms at 914 and 936 m/z, and tris-chlorohydrin forms at
968 and 990 m/z.
Fig. 3. The e¡ect of phospholipid chlorohydrins on HL60 cell ATP
levels. Cells were incubated for 24 h in RPMI-1640 medium con-
taining the phospholipid chlorohydrins at the concentrations indi-
cated in the graphs, and subsequently the cellular ATP level was de-
termined as described in Fig. 1. In each graph the e¡ect of the
native (unoxidised) lipid was compared with that of the chlorohy-
drin: SOPC (top), SLPC (middle), and SAPC (bottom). The data
are the average of three separate experiments each carried out in
triplicate, and the error bars correspond to 1 S.D.
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the 24 h incubation by staining with trypan blue, but no sig-
ni¢cant di¡erences between chlorohydrin-treated and control
cells were found. Subsequently, a bioluminescent method that
uses luciferin and luciferase to detect cytosolic ATP was
tested, as this has been reported to o¡er a sensitive method
for monitoring viability [15].
Following treatment of the cells with chlorohydrins or na-
tive lipids for 24 h, the cytosolic ATP levels were determined,
and the results are shown in Fig. 3. Native SOPC was not
found to have any e¡ect on the cellular ATP levels over the
concentration range tested, whereas SOPC chlorohydrin
clearly caused a dose-dependent depletion of ATP, with 50%
loss at 25 WM and almost complete depletion occurring at 100
WM chlorohydrin. The results with SLPC chlorohydrin were
similar to those obtained with SOPC, but the e¡ect on cellular
ATP was slightly more marked at the higher concentrations.
However, the native lipid was observed to cause a small de-
pletion of ATP at 100 and 200 WM, in contrast to the mono-
unsaturated phospholipid. SAPC chlorohydrin also clearly
caused ATP depletion, although the e¡ect was apparently
less than that found with the other two phospholipids. How-
ever, the conversion of SAPC to chlorohydrins was observed
to be incomplete, with on average only about 40% conversion
occurring; thus the e¡ect of this chlorohydrin is actually
greater than that of the chlorohydrins of the more saturated
lipids. A striking response to the native SAPC was also ob-
served, as the cells showed signi¢cant loss of ATP at concen-
trations of 25 WM and above. The responses of U937 cells to
all the phospholipid chlorohydrins were almost identical to
those observed with HL60 cells (data not shown).
Fig. 4 shows the results of an experiment to investigate the
timescale of the e¡ects observed with chlorohydrins. U937
cells were treated with 100 WM SOPC chlorohydrin and moni-
tored at intervals over a timecourse of 24 h. It can be seen
that chlorohydrin treatment caused very little loss of ATP
over the ¢rst 4 h of the incubation, whereas at 6^8 h a small
decrease in [ATP] was apparent, and at 22 and 24 h there was
substantial ATP depletion.
Experiments were also carried out on U937 cells with HNE
and SOPC chlorohydrin in medium containing only 0.5% foe-
tal calf serum, to determine whether this increased the sensi-
tivity of the cells to these compounds, but there was not found
to be a signi¢cant di¡erence between the dose-dependent re-
sponse at 10% and 0.5% serum, for either of the treatments
(data not shown).
It has previously been found that a number of esteri¢ed
oxidation products of PAPC have bioactive e¡ects such as
the induction of monocyte-endothelial binding [16,17]. These
compounds have been observed in the arterial vessels of hy-
percholestaemic rabbits, and can be formed in vitro by the
Fig. 4. Time dependence of ATP depletion by SOPC chlorohydrin.
U937 cells were incubated with 100 WM SOPC chlorohydrin for the
timecourse shown, and at each timepoint the intracellular ATP level
was determined by bioluminescence as described in Fig. 1. The data
are the average of four separate experiments each carried out in
triplicate, and the error bars correspond to 1 S.D.
Fig. 5. The e¡ect of autoxidised PAPC on ATP levels in HL60 and
U937 cells. The autoxidation of PAPC and product composition
were determined by ESMS (top). The native PAPC at 782 m/z has
been converted to oxidised derivatives (810, 828, 846, 860, and 878
m/z) and chain-shortened derivatives at 594 and 610 m/z. HL60 cells
(middle) and U937 cells (bottom) were incubated for 24 h in
RPMI-1640 medium containing the autoxidised PAPC mixture at
the concentrations indicated in the graphs, and subsequently the
ATP level was determined as described in Fig. 1. With each cell
type the e¡ect of native (unoxidised) PAPC was monitored for com-
parison. The data are the average of three separate experiments
each carried out in triplicate, and the error bars correspond to
1 S.D.
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autoxidation of PAPC. Analogous experiments were therefore
also carried out with autoxidised PAPC to allow comparison
of the phospholipid chlorohydrins with other oxidised phos-
pholipids of established bioactivity. The autoxidised PAPC
was analysed by ESMS, and showed a very comparable pro-
¢le of oxidation products to that which was observed to have
bioactive e¡ects in previous studies. The autoxidised PAPC
mixture was found to cause loss of ATP at concentrations
of 100 WM and above, both with HL60 and U937 cells (Fig.
5). A small ATP depletion was also observed with the native
PAPC, especially in U937 cells.
To investigate whether the changes in cytosolic ATP were
related to changes in cell viability, experiments were also car-
ried out using the MTT assay as an alternative method for
measuring viable cells. Fig. 6 shows the e¡ect of SOPC chlo-
rohydrin and HNE on U937 cell viability according to this
assay. It can be seen that the SOPC chlorohydrin (Fig. 6a)
caused a dose-dependent loss of viability, with concentrations
of 25 WM causing substantial loss of viability and only 20%
viability remaining at 200 WM. With this assay it was also
apparent that HNE was more toxic than the chlorohydrin,
with substantial loss of viability at 25 WM, and fewer than
10% of viable cells remaining after treatments with 50 WM
HNE.
4. Discussion
The results presented clearly show that phosphatidylcholine
chlorohydrins cause the depletion of cytosolic ATP in human
myeloid cells. Surprisingly, there was not a great di¡erence
between the e¡ects of the three chlorohydrins tested; they
caused approximately a 50% loss of ATP at 25 WM, and al-
most complete depletion at 100 WM. There was evidence of
some increase in e¡ect with increasing unsaturation, corre-
sponding to increasing substitution, but the extent of chloro-
hydrin substitution did not a¡ect the ATP depletion as much
as had been expected.
In terms of a comparison with other lipid oxidation prod-
ucts, the chlorohydrins caused more ATP depletion than the
alkenals tested (hexanal and trans-2-nonenal), but were some-
what less e¡ective than HNE, which is known to be one of the
most deleterious aldehyde products of lipid peroxidation. The
e¡ect of HNE on the two cell lines tested, HL60 and U937,
was in general agreement with previous reports that HNE
concentrations of 1^100 WM cause various e¡ects including
toxicity, apoptosis, chemotaxis and di¡erentiation in a variety
of cells [18^20]. It was thought that the presence of foetal calf
serum during the incubation might have decreased the e¡ect
of the HNE, although experiments with a reduced level of
foetal calf serum (0.5%) were not found to increase the ATP
depletion. Possibly even a small amount of foetal calf serum
can inactivate HNE, but incubation of the mammalian cells
without serum over this timecourse was not feasible. The ef-
fects of the phospholipid chlorohydrins were also compared to
that of autoxidised PAPC, which has previously been used as
a model for the bioactive lipid oxidation products found in
minimally modi¢ed LDL [17]. Each of the individual chloro-
hydrins caused more ATP depletion in the cells tested than the
oxidised PAPC mixture; this may re£ect the fact that more
than a dozen di¡erent products are present in this treatment,
not all of which may be toxic, although three products iden-
ti¢ed as having high bioactivity in previous studies were
substantial components of the mixture. Thus it is possible
that individual components of the oxidised PAPC have a sim-
ilar ability to deplete ATP to the chlorohydrins, but in com-
bination as a model for oxLDL, the depletion induced was
lower.
The CellTitre-GloTM Luminescence assay is marketed as a
sensitive method for measuring the viability of mammalian
cells, and its application has been reported previously in sev-
eral studies [15,21,22]. While small £uctuations in cellular
ATP levels may occur in viable cells, severe depletion of
ATP to less than 5% of normal values is likely to correspond
to a substantial loss of cell viability. To test this, experiments
were also carried out using the MTT assay as an alternative
and well established method for monitoring viability, and
these showed that SOPC chlorohydrin did cause loss of cell
viability (i.e. it was toxic to the cells) at comparable concen-
trations to those that caused depletion of cellular ATP. Sim-
ilarly, HNE treatment of the cells also caused loss of viability,
although the toxicity was somewhat lower than expected; this
may be due to the presence of foetal calf serum as mentioned
earlier. In both cases, the loss of ATP was more severe than
the loss of viability at any one treatment concentration. Thus
it can be seen that ATP depletion correlates reasonably, but
not exactly, with loss of viability measured by a conventional
method. It is possible that depletion of ATP is an earlier event
Fig. 6. The e¡ect of SOPC chlorohydrin and HNE on cell viability
determined by the MTT assay. U937 cells (1U105 cells/well in a 96-
well plate) were incubated with SOPC chlorohydrin at concentra-
tions of 10^200 WM (a) and HNE at concentrations of 1^100 WM
(b) for 24 h. The cells were incubated with MTT reagent (0.5 mg/
ml) for 90 min before centrifuging and resuspending in 3:1
DMSO:isopropanol. The absorbance was read at 540 nm in a pla-
tereader, and the data are presented as a comparison with control
cell viability. The data are the average of four separate experiments
each carried out in triplicate, and the error bars correspond to
1 S.D.
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than loss of dehydrogenase function in the process of cell
death.
However, neither of these methods distinguishes between
apoptosis and necrosis, as both types of cell death involve
decreases in cytosolic ATP levels and loss of cell function.
In previous studies of oleic acid chlorohydrins it has been
reported that they result in membrane damage in erythrocytes
[23] and in endothelial cells [13], and that a necrotic mecha-
nism is responsible for the loss of viability. In this study, no
signi¢cant uptake of trypan blue was observed following
chlorohydrin treatment, but as trypan blue has been reported
to be considerably less sensitive than ATP bioluminescence in
determining cell viability [21], it cannot be concluded that no
loss of membrane integrity occurred. On the other hand, the
relatively long timescale of ATP depletion suggests that the
toxicity of phospholipid chlorohydrins may involve a more
complex process than direct incorporation into and disruption
of the membrane. It is also possible that the depletion of
cellular ATP represents an early event in the process of tox-
icity, and that membrane disruption due to necrotic cell death
might occur at a later stage. It was found that the toxicity of
SOPC chlorohydrin measured by the MTT assay was some-
what lower than that reported previously for oleic acid chlo-
rohydrin [13], taking into account the di¡erence in incubation
times and the method of assessment of viability.
An interesting point noted was the increasing e¡ect of the
native phosphatidylcholines with increasing unsaturation of
the fatty acyl chain; a substantial ATP depletion was ob-
served with the polyunsaturated SAPC. Reports in the liter-
ature vary considerably with regard to the toxicity of unmodi-
¢ed fatty acids and phospholipids: there have been reports
that SAPC had no toxicity to tumour cell lines [24], arachi-
donic acid causes apoptosis [25], and polyunsaturated fatty
acids have selective cytotoxic and cytostatic e¡ects [26]. How-
ever, in view of the fact that the cells tested are of myeloid
lineage, it is probable that the e¡ect observed is due to oxi-
dation of the phospholipid by the cells to give a toxic product,
as has been observed in similar situations for LDL incubated
with various cell types [27].
Our results show that intact phospholipid chlorohydrins,
which could be formed from LDL phospholipids in athero-
sclerotic plaques, cause substantial depletion of ATP and loss
of viability in cells of a myeloid lineage, such as monocytes
and macrophages which are known to be present in plaques.
Such e¡ects could contribute to the formation of the necrotic
core in advanced lesions.
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